title: NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.
abstract: The combined deletion of 1p and 19q chromosomal arms is frequent in oligodendrogliomas (OD) and has recently been shown to be mediated by an unbalanced t(1;19) translocation. Recent studies of 1p/19q co-deleted OD suggest that the NOTCH2 gene is implicated in oligodendrocyte differentiation and may be involved in this rearrangement. The objective of the present study was to analyze the NOTCH2 locus either as a chromosomal translocation locus that may be altered by the 1p/19q recurrent rearrangement or as a gene that may be inactivated by a two hit process. We performed an array-CGH analysis of 15 ODs presenting 1p/19q co-deletion using a high-density oligonucleotide microarray spanning 1p and 19q pericentromeric regions with 377 bp average probe spacing. We showed that the 1p deletion extends to the centromere of chromosome 1 and includes the entire NOTCH2 gene. No internal rearrangement of this gene was observed. This strongly suggests that the t(1;19) translocation does not lead to an abnormal NOTCH2 structure. The analysis of the entire NOTCH2 coding sequence was performed in four cases and did not reveal any mutation therefore indicating that NOTCH2 does not harbor genetic characteristics of a tumor suppressor gene. Finally, the detailed analysis of chromosome 19 pericentromeric region led to the identification of two breakpoint clusters at 19p12 and 19q11-12. Interestingly, these two regions share a large stretch of homology. Together with previous observations of similarities between chromosome 1 and 19 alphoid sequences, this suggests that the t(1;19) translocation arises from complex intra and interchromosomal rearrangements.This is the first comprehensive deletion mapping by high density oligo-array of the 1p/19q co-deletion in oligodendroglioma tumors using a methodological approach superior to others previously applied. As such this paper provides clear evidence that the NOTCH2 gene is not physically rearranged by t(1;19) translocation of oligodendroglioma tumors.
authors.affiliation: INSERM, Unité 830, Paris, France.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Benetkiewicz
authors.forename: Ahmed
authors.initials: A
authors.lastname: Idbaih
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Cousin
authors.forename: Blandine
authors.initials: B
authors.lastname: Boisselier
authors.forename: Yannick
authors.initials: Y
authors.lastname: Marie
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Crinière
authors.forename: Khê
authors.initials: K
authors.lastname: Hoang-Xuan
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Delattre
authors.forename: Marc
authors.initials: M
authors.lastname: Sanson
authors.forename: Olivier
authors.initials: O
authors.lastname: Delattre
mesh_terms: D001483:Base Sequence; D001932:Brain Neoplasms / Q000235:genetics / Q000378:metabolism; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D004252:DNA Mutational Analysis; D015321:Gene Rearrangement; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D009837:Oligodendroglioma / Q000235:genetics / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D051883:Receptor, Notch2 / Q000235:genetics* / Q000378:metabolism; D014178:Translocation, Genetic
chemical_list: C497764:NOTCH2 protein, human; D051883:Receptor, Notch2